Further studies need to validate our observation, which, however, can be considered to support the hypothesis that our NBS protocol is able to detect most SMA carriers with one SMN1 copy, as already reported for other qPCR-based NBS for SMA [25,26]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.